RCM Technologies, Inc. (RCMT) Financials

RCMT Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 135.3 million 91.0 million
Dec. 31, 2025 134.4 million 88.4 million
Sept. 30, 2025 129.8 million 88.4 million
June 30, 2025 135.6 million 97.8 million

RCMT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 2.6 million 1.0 million
Dec. 31, 2025 11.2 million 793000
Sept. 30, 2025 -1.8 million 1.0 million
June 30, 2025 -8.4 million 1.1 million

RCMT Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 3.8 million
Dec. 31, 2025 16.3 million
Sept. 30, 2025 2.3 million
June 30, 2025 3.8 million

RCMT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.6 million 28.8 million 3.7 million
Dec. 31, 2025 2.9 million 24.7 million 1.2 million
Sept. 30, 2025 1.3 million 31.5 million 4.4 million
June 30, 2025 5.5 million 34.0 million 6.6 million

RCMT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 7.6 million
Dec. 31, 2025 7.4 million
Sept. 30, 2025 7.6 million
June 30, 2025 7.5 million

RCMT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 97000 - 15.5 million -
Dec. 31, 2025 197000 - 15.8 million -
Sept. 30, 2025 498000 - 14.9 million -
June 30, 2025 473000 - 15.3 million -

RCMT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 83.0 million 61.6 million
Dec. 31, 2025 86.5 million 62.8 million
Sept. 30, 2025 70.3 million 51.4 million
June 30, 2025 78.2 million 56.3 million

RCMT Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RCMT

Price: $23.88

52 week price:
17.26
32.50

Payout Ratio Range:
421.00%
4858.17%

Earnings Per Share: 2.12 USD

P/E Ratio: 10.60

Exchange: NGM

Sector: Industrials

Industry: Conglomerates

Country: United States

Volume: 27500

Ebitda: 4.2 million

Market Capitalization: 159.2 million

Average Dividend Frequency: 1

Links: